New adjunct chemo cures twice as many people with cancer and has been shown to increase tolerance to chemo so everybody can take their medicine.
Yet, I have been attacked for posting these promising medical studies.
The medicine is real and the results are real too!
Any idea why medical professions have a negative sentiment to a new cure?
_____________________________________________
Novelos has announced positive results of a phase I/II trial of NOV-002, for the treatment of non-small cell lung cancer. The drug is currently approved in Russia, where it is marketed as Glutomix. Intent-to-treat analysis indicated that 69% (11/16) of subjects receiving intravenous (IV) and subcutaneous (SC) NOV-002 in combination with chemotherapy achieved objective (complete or partial) tumor response, vs. 33% (5/15) receiving chemotherapy alone (p=0.044). Subjects receiving NOV-002 via IV and intramuscular (IM) injection plus chemotherapy experienced a non-significant 46% (6/13) objective response rate. The drug also produced improved tolerance of chemotherapy in both dosing groups, with 100% of the IV/SC and 85% of the IV/IM subjects completing 4 cycles of chemotherapy, vs. 50% of subjects receiving chemotherapy alone (p=0.004). This randomized, controlled study enrolled 44 patients, who received one of two regimens of NOV-002 (IV/SC or IV/IM) plus chemotherapy or chemotherapy alone for 6 months. The company announced plans to initiate phase II/III trials of the drug in 2006, based on these results.
2007-01-23
03:37:05
·
3 answers
·
asked by
Bixbyte
4
in
Health
➔ Diseases & Conditions
➔ Cancer
See results about Novelos Therapeutics:
http://www.centerwatch.com/patient/nmtresults/nmt050815.html
2007-01-23
03:38:54 ·
update #1
With Phase II drug trial results that show standard cancer chemo is only 33% effective and that only 50% (half) the patients are incapable of tolerating standard Cancer ChemoTherapy.
I find it shocking that nobody is doing anything to save lives of people with Cancer! Trials so far show NOV-002 increases patients tolerance to chemtherapy so that 100% (all) the patients could tolerate the standard chemo yet Docotrs are stalling and attacking my posts. I have even wrote letters to doctors with the results and the new drug trials available of NOV-002 to save lives. Yet, I have not received a single reply!
2007-01-23
04:44:10 ·
update #2